Table 3. In Vitro Cytotoxic Activities of p-SC6, Harmala Alkaloid-Rich Fraction, and H/p-SC6 Nanocapsules against SKOV-3, MCF-7, and Human Skin Fibroblastsa.
|
in
vitro cytotoxic activity (IC50 in μg/mL) |
|||
|---|---|---|---|
| cells | p-SC6 | harmala alkaloid-rich fraction (positive control) | H/p-SC6 |
| SKOV-3 | >300 | 6.7 ± 1.6 | 5 ± 1.3 |
| MCF-7 | >220 | 6.7 ± 0.7 | 2.3 ± 1.1 |
| human skin fibroblasts | >300 | 4.6 ± 1.5 | >300 |
The treatment period was 48 h. Data represent the mean ± standard deviation of triplicate.